APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antithrombin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antithrombin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173966640321 December 2025189 pages

Choose your research edition.

Industry ResearchAntithrombin Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithrombin Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Antithrombin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithrombin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithrombin Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Antithrombin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Antithrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antithrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antithrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antithrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antithrombin include Takeda, Scripps Laboratories Inc., Grifols, rEVO Biologics Inc., Lee Biosolutions, Kedrion S.p.A. and CSL Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Antithrombin market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antithrombin and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antithrombin revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Antithrombin market size, projected growth trends, production technologies, key applications, and end-use industries.

Antithrombin Segment by Company

Takeda

Scripps Laboratories Inc.

Grifols

rEVO Biologics Inc.

Lee Biosolutions

Kedrion S.p.A.

CSL Limited

Antithrombin Segment by Type

Liquid

Lyophilized

Antithrombin Segment by Application

Diagnostics

Research

Therapeutics

Antithrombin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithrombin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithrombin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithrombin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Antithrombin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antithrombin industry.

Chapter 3: Detailed analysis of Antithrombin companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antithrombinrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antithrombin Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Liquid Table 3. Key Players of Lyophilized Table 4. Global Antithrombin Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Diagnostics Table 6. Key Players of Research Table 7. Key Players of Therapeutics Table 8. Global Antithrombin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Antithrombin Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Antithrombin Market Share by Region (2021-2026) Table 11. Global Antithrombin Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Antithrombin Market Share by Region (2027-2032) Table 13. Antithrombin Industry Trends Table 14. Antithrombin Industry Drivers Table 15. Antithrombin Industry Opportunities and Challenges Table 16. Antithrombin Industry Restraints Table 17. Global Antithrombin Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Antithrombin Revenue Market Share by Company (2021-2026) Table 19. Global Antithrombin Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Antithrombin Key Company Head Office and Area Served Table 21. Global Antithrombin Company, Product Type & Application Table 22. Global Antithrombin Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Antithrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Antithrombin Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antithrombin Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Antithrombin Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Antithrombin Revenue Market Share by Type (2021-2026) Table 29. Global Antithrombin Revenue Market Share by Type (2027-2032) Table 30. Global Antithrombin Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Antithrombin Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Antithrombin Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Antithrombin Revenue Market Share by Application (2021-2026) Table 34. Global Antithrombin Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Antithrombin Product Portfolio Table 39. Takeda Recent Development Table 40. Scripps Laboratories Inc. Company Information Table 41. Scripps Laboratories Inc. Business Overview Table 42. Scripps Laboratories Inc. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Scripps Laboratories Inc. Antithrombin Product Portfolio Table 44. Scripps Laboratories Inc. Recent Development Table 45. Grifols Company Information Table 46. Grifols Business Overview Table 47. Grifols Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Grifols Antithrombin Product Portfolio Table 49. Grifols Recent Development Table 50. rEVO Biologics Inc. Company Information Table 51. rEVO Biologics Inc. Business Overview Table 52. rEVO Biologics Inc. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. rEVO Biologics Inc. Antithrombin Product Portfolio Table 54. rEVO Biologics Inc. Recent Development Table 55. Lee Biosolutions Company Information Table 56. Lee Biosolutions Business Overview Table 57. Lee Biosolutions Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Lee Biosolutions Antithrombin Product Portfolio Table 59. Lee Biosolutions Recent Development Table 60. Kedrion S.p.A. Company Information Table 61. Kedrion S.p.A. Business Overview Table 62. Kedrion S.p.A. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Kedrion S.p.A. Antithrombin Product Portfolio Table 64. Kedrion S.p.A. Recent Development Table 65. CSL Limited Company Information Table 66. CSL Limited Business Overview Table 67. CSL Limited Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. CSL Limited Antithrombin Product Portfolio Table 69. CSL Limited Recent Development Table 70. North America Antithrombin Market Size by Type (2021-2026) & (US$ Million) Table 71. North America Antithrombin Market Size by Type (2027-2032) & (US$ Million) Table 72. North America Antithrombin Market Size by Application (2021-2026) & (US$ Million) Table 73. North America Antithrombin Market Size by Application (2027-2032) & (US$ Million) Table 74. North America Antithrombin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Antithrombin Market Size by Country (2021-2026) Table 76. North America Antithrombin Market Size by Country (2027-2032) Table 77. Europe Antithrombin Market Size by Type (2021-2026) & (US$ Million) Table 78. Europe Antithrombin Market Size by Type (2027-2032) & (US$ Million) Table 79. Europe Antithrombin Market Size by Application (2021-2026) & (US$ Million) Table 80. Europe Antithrombin Market Size by Application (2027-2032) & (US$ Million) Table 81. Europe Antithrombin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Antithrombin Market Size by Country (2021-2026) Table 83. Europe Antithrombin Market Size by Country (2027-2032) Table 84. China Antithrombin Market Size by Type (2021-2026) & (US$ Million) Table 85. China Antithrombin Market Size by Type (2027-2032) & (US$ Million) Table 86. China Antithrombin Market Size by Application (2021-2026) & (US$ Million) Table 87. China Antithrombin Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Antithrombin Market Size by Type (2021-2026) & (US$ Million) Table 89. Asia Antithrombin Market Size by Type (2027-2032) & (US$ Million) Table 90. Asia Antithrombin Market Size by Application (2021-2026) & (US$ Million) Table 91. Asia Antithrombin Market Size by Application (2027-2032) & (US$ Million) Table 92. Asia Antithrombin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Antithrombin Market Size by Country (2021-2026) Table 94. Asia Antithrombin Market Size by Country (2027-2032) Table 95. South America, Middle East & Africa Antithrombin Market Size by Type (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Antithrombin Market Size by Type (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Antithrombin Market Size by Application (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Antithrombin Market Size by Application (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Antithrombin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. South America, Middle East & Africa Antithrombin Market Size by Country (2021-2026) Table 101. South America, Middle East & Africa Antithrombin Market Size by Country (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Antithrombin Product Image Figure 2. Global Antithrombin Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Antithrombin Market Share by Type: 2025 VS 2032 Figure 4. Liquid Image Figure 5. Lyophilized Image Figure 6. Global Antithrombin Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Antithrombin Market Share by Application: 2025 VS 2032 Figure 8. Diagnostics Image Figure 9. Research Image Figure 10. Therapeutics Image Figure 11. Global Antithrombin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Antithrombin Market Size (2021-2032) & (US$ Million) Figure 13. Global Antithrombin Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Antithrombin Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Antithrombin Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Antithrombin Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Antithrombin Revenue Market Share by Type (2021-2032) Figure 20. Global Antithrombin Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Antithrombin Revenue Market Share by Application (2021-2032) Figure 22. North America Antithrombin Market Size (2021-2032) & (US$ Million) Figure 23. North America Antithrombin Market Share by Type (2021-2032) Figure 24. North America Antithrombin Market Share by Application (2021-2032) Figure 25. North America Antithrombin Market Share by Country (2021-2032) Figure 26. United States Antithrombin Market Size (2021-2032) & (US$ Million) Figure 27. Canada Antithrombin Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Antithrombin Market Size (2021-2032) & (US$ Million) Figure 29. Europe Antithrombin Market Size (2021-2032) & (US$ Million) Figure 30. Europe Antithrombin Market Share by Type (2021-2032) Figure 31. Europe Antithrombin Market Share by Application (2021-2032) Figure 32. Europe Antithrombin Market Share by Country (2021-2032) Figure 33. Germany Antithrombin Market Size (2021-2032) & (US$ Million) Figure 34. France Antithrombin Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Antithrombin Market Size (2021-2032) & (US$ Million) Figure 36. Italy Antithrombin Market Size (2021-2032) & (US$ Million) Figure 37. Russia Antithrombin Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Antithrombin Market Size (2021-2032) & (US$ Million) Figure 39. China Antithrombin Market Size (2021-2032) & (US$ Million) Figure 40. China Antithrombin Market Share by Type (2021-2032) Figure 41. China Antithrombin Market Share by Application (2021-2032) Figure 42. Asia Antithrombin Market Size (2021-2032) & (US$ Million) Figure 43. Asia Antithrombin Market Share by Type (2021-2032) Figure 44. Asia Antithrombin Market Share by Application (2021-2032) Figure 45. Asia Antithrombin Market Share by Country (2021-2032) Figure 46. Japan Antithrombin Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Antithrombin Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Antithrombin Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Antithrombin Market Size (2021-2032) & (US$ Million) Figure 50. India Antithrombin Market Size (2021-2032) & (US$ Million) Figure 51. Australia Antithrombin Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Antithrombin Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Antithrombin Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Antithrombin Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Antithrombin Market Share by Country (2021-2032) Figure 56. Brazil Antithrombin Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Antithrombin Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Antithrombin Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Antithrombin Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Antithrombin Market Size (2021-2032) & (US$ Million) Figure 61. UAE Antithrombin Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Antithrombin Market Size (2021-2032) & (US$ Million) Figure 63. Chile Antithrombin Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Lyophilized
Applications
  • Diagnostics
  • Research
  • Therapeutics
Companies covered
  • Takeda
  • Scripps Laboratories Inc.
  • Grifols
  • rEVO Biologics Inc.
  • Lee Biosolutions
  • Kedrion S.p.A.
  • CSL Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Antithrombin Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid
  5. 1.2.3 Lyophilized
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Antithrombin Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Diagnostics
  9. 1.3.3 Research
  10. 1.3.4 Therapeutics
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Antithrombin Growth Trends by Region
  13. 1.5.1 Global Antithrombin Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Antithrombin Market Size by Region (2021-2026)
  15. 1.5.3 Antithrombin Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Antithrombin Market Dynamics
  1. 2.1 Antithrombin Industry Trends
  2. 2.2 Antithrombin Industry Drivers
  3. 2.3 Antithrombin Industry Opportunities and Challenges
  4. 2.4 Antithrombin Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Antithrombin Revenue by Company (2021-2026)
  2. 3.2 Global Antithrombin Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Antithrombin Key Company Head office and Area Served
  4. 3.4 Global Antithrombin Company, Product Type & Application
  5. 3.5 Global Antithrombin Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Antithrombin Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Antithrombin Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Antithrombin Tier 1, Tier 2, and Tier 3
4 Antithrombin Market by Type
  1. 4.1 Global Antithrombin Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Antithrombin Market Size by Type (2021-2032)
  3. 4.3 Global Antithrombin Market Size Share by Type (2021-2032)
5 Antithrombin Market by Application
  1. 5.1 Global Antithrombin Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Antithrombin Market Size by Application (2021-2032)
  3. 5.3 Global Antithrombin Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Antithrombin Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Scripps Laboratories Inc.
  8. 6.2.1 Scripps Laboratories Inc. Company Information
  9. 6.2.2 Scripps Laboratories Inc. Business Overview
  10. 6.2.3 Scripps Laboratories Inc. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Scripps Laboratories Inc. Antithrombin Product Portfolio
  12. 6.2.5 Scripps Laboratories Inc. Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Grifols Antithrombin Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 rEVO Biologics Inc.
  20. 6.4.1 rEVO Biologics Inc. Company Information
  21. 6.4.2 rEVO Biologics Inc. Business Overview
  22. 6.4.3 rEVO Biologics Inc. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 rEVO Biologics Inc. Antithrombin Product Portfolio
  24. 6.4.5 rEVO Biologics Inc. Recent Developments
  25. 6.5 Lee Biosolutions
  26. 6.5.1 Lee Biosolutions Company Information
  27. 6.5.2 Lee Biosolutions Business Overview
  28. 6.5.3 Lee Biosolutions Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Lee Biosolutions Antithrombin Product Portfolio
  30. 6.5.5 Lee Biosolutions Recent Developments
  31. 6.6 Kedrion S.p.A.
  32. 6.6.1 Kedrion S.p.A. Company Information
  33. 6.6.2 Kedrion S.p.A. Business Overview
  34. 6.6.3 Kedrion S.p.A. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Kedrion S.p.A. Antithrombin Product Portfolio
  36. 6.6.5 Kedrion S.p.A. Recent Developments
  37. 6.7 CSL Limited
  38. 6.7.1 CSL Limited Company Information
  39. 6.7.2 CSL Limited Business Overview
  40. 6.7.3 CSL Limited Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 CSL Limited Antithrombin Product Portfolio
  42. 6.7.5 CSL Limited Recent Developments
7 North America
  1. 7.1 North America Antithrombin Market Size (2021-2032)
  2. 7.2 North America Antithrombin Market Size by Type
  3. 7.2.1 North America Antithrombin Market Size by Type (2021-2026)
  4. 7.2.2 North America Antithrombin Market Size by Type (2027-2032)
  5. 7.2.3 North America Antithrombin Market Share by Type (2021-2032)
  6. 7.3 North America Antithrombin Market Size by Application
  7. 7.3.1 North America Antithrombin Market Size by Application (2021-2026)
  8. 7.3.2 North America Antithrombin Market Size by Application (2027-2032)
  9. 7.3.3 North America Antithrombin Market Share by Application (2021-2032)
  10. 7.4 North America Antithrombin Market Size by Country
  11. 7.4.1 North America Antithrombin Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Antithrombin Market Size by Country (2021-2026)
  13. 7.4.3 North America Antithrombin Market Size by Country (2027-2032)
  14. 7.4.4 North America Antithrombin Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Antithrombin Market Size (2021-2032)
  2. 8.2 Europe Antithrombin Market Size by Type
  3. 8.2.1 Europe Antithrombin Market Size by Type (2021-2026)
  4. 8.2.2 Europe Antithrombin Market Size by Type (2027-2032)
  5. 8.2.3 Europe Antithrombin Market Share by Type (2021-2032)
  6. 8.3 Europe Antithrombin Market Size by Application
  7. 8.3.1 Europe Antithrombin Market Size by Application (2021-2026)
  8. 8.3.2 Europe Antithrombin Market Size by Application (2027-2032)
  9. 8.3.3 Europe Antithrombin Market Share by Application (2021-2032)
  10. 8.4 Europe Antithrombin Market Size by Country
  11. 8.4.1 Europe Antithrombin Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Antithrombin Market Size by Country (2021-2026)
  13. 8.4.3 Europe Antithrombin Market Size by Country (2027-2032)
  14. 8.4.4 Europe Antithrombin Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Antithrombin Market Size (2021-2032)
  2. 9.2 China Antithrombin Market Size by Type
  3. 9.2.1 China Antithrombin Market Size by Type (2021-2026)
  4. 9.2.2 China Antithrombin Market Size by Type (2027-2032)
  5. 9.2.3 China Antithrombin Market Share by Type (2021-2032)
  6. 9.3 China Antithrombin Market Size by Application
  7. 9.3.1 China Antithrombin Market Size by Application (2021-2026)
  8. 9.3.2 China Antithrombin Market Size by Application (2027-2032)
  9. 9.3.3 China Antithrombin Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Antithrombin Market Size (2021-2032)
  2. 10.2 Asia Antithrombin Market Size by Type
  3. 10.2.1 Asia Antithrombin Market Size by Type (2021-2026)
  4. 10.2.2 Asia Antithrombin Market Size by Type (2027-2032)
  5. 10.2.3 Asia Antithrombin Market Share by Type (2021-2032)
  6. 10.3 Asia Antithrombin Market Size by Application
  7. 10.3.1 Asia Antithrombin Market Size by Application (2021-2026)
  8. 10.3.2 Asia Antithrombin Market Size by Application (2027-2032)
  9. 10.3.3 Asia Antithrombin Market Share by Application (2021-2032)
  10. 10.4 Asia Antithrombin Market Size by Country
  11. 10.4.1 Asia Antithrombin Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Antithrombin Market Size by Country (2021-2026)
  13. 10.4.3 Asia Antithrombin Market Size by Country (2027-2032)
  14. 10.4.4 Asia Antithrombin Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Antithrombin Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Antithrombin Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Antithrombin Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Antithrombin Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Antithrombin Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Antithrombin Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Antithrombin Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Antithrombin Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Antithrombin Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Antithrombin Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Antithrombin Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Antithrombin Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Antithrombin Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Antithrombin Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst